Dear Sir/Madam, Please find the attached Scrutinizer''s Report for 23rd Annual General Meeting of the company held for the financial year ended 31st March, 2025 on 30th September, 2025 ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy held its 23rd AGM on 30th September 2025 via video conferencing. All four resolutions were passed with overwhelming shareholder support (99.5%–99.7% in favour). The resolutions included adoption of FY2025 financial statements, re-appointment of Mrs. Sakshi Laller as a director, ratification of M/s. Garg Mendiratta and Associates as the new statutory auditor (filling a casual vacancy caused by the resignation of M/s. Harjeet Parvesh and Company), and approval of related party transactions. E-voting was conducted through NSDL, with the scrutinizer unblocking votes on 30th September 2025 at 3:35 PM. Related parties were excluded from voting on resolutions 2 and 4 where they had a direct interest.
The change of statutory auditor (from Harjeet Parvesh to Garg Mendiratta) is the most material event for shareholders to note. All routine AGM items were approved easily, indicating no significant shareholder dissent on the company's FY2025 results or governance matters.